Cargando…

Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans

BACKGROUND: The current strategy for the elimination of onchocerciasis is based on annual or bi-annual mass drug administration with ivermectin. However, due to several limiting factors there is a growing concern that elimination of onchocerciasis cannot be achieved solely through the current strate...

Descripción completa

Detalles Bibliográficos
Autores principales:	George, Parakkal Jovvian, Hess, Jessica A., Jain, Sonia, Patton, John B., Zhan, Tingting, Tricoche, Nancy, Zhan, Bin, Bottazzi, Maria Elena, Hotez, Peter J., Abraham, David, Lustigman, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762197/ https://www.ncbi.nlm.nih.gov/pubmed/31525197 http://dx.doi.org/10.1371/journal.pntd.0007730

Ejemplares similares

The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice
por: Hess, Jessica A., et al.
Publicado: (2016)

Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
por: Luu, Lisa, et al.
Publicado: (2022)

Nodding syndrome (NS) and Onchocerca Volvulus (OV) in Northern Uganda
por: Lagoro, David Kitara, et al.
Publicado: (2017)

The Onchocerca volvulus Cysteine Proteinase Inhibitor, Ov-CPI-2, Is a Target of Protective Antibody Response That Increases with Age
por: Cho-Ngwa, Fidelis, et al.
Publicado: (2010)

Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus
por: Shey, Robert Adamu, et al.
Publicado: (2018)

The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates
por: Wang, Jing, et al.
Publicado: (2012)

Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
por: Vlaminck, Johnny, et al.
Publicado: (2019)

Human immune responses to infective stage larval-specific chitinase of filarial parasite, Onchocerca volvulus, Ov-CHI-1.
por: Wu, Yang, et al.
Publicado: (2003)

Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein
por: Njume, Ferdinand Ngale, et al.
Publicado: (2019)

Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus
Publicado: (1995)

Performance evaluation of 3 serodiagnostic peptide epitopes and the derived multi-epitope peptide OvNMP-48 for detection of Onchocerca volvulus infection
por: Lagatie, Ole, et al.
Publicado: (2019)

Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to Onchocerca volvulus in Mice and Non-Human Primates
por: Ryan, Nathan M., et al.
Publicado: (2023)

Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection
por: Arumugam, Sridhar, et al.
Publicado: (2016)

Ov2 is a modulator of OvHV-2 RTA mediated gene expression
por: Dry, Inga, et al.
Publicado: (2019)

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis
por: Jawahar, Shabnam, et al.
Publicado: (2021)

Nouveau coronavirus (NcOV)
por: Bricaire, François
Publicado: (2013)

Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum
por: Patton, John B., et al.
Publicado: (2018)

Evaluation of glycoprotein Ov8 as a potential antigen for an OvHV-2-specific diagnostic assay
por: Alhajri, Salim M., et al.
Publicado: (2018)

Deletion of gene OV132 attenuates Orf virus more effectively than gene OV112
por: Yamada, Yumiko, et al.
Publicado: (2022)

Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi
por: Zhan, Bin, et al.
Publicado: (2022)

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2021)

Preliminary evaluations of 3-dimensional human skin models for their ability to facilitate in vitro the long-term development of the debilitating obligatory human parasite Onchocerca volvulus
por: Malkmus, Christoph, et al.
Publicado: (2020)

Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis
por: Lustigman, Sara, et al.
Publicado: (2007)

Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice
por: Ryan, Nathan M., et al.
Publicado: (2021)

The NR3B subgroup: an ovERRview
por: Tremblay, Annie M., et al.
Publicado: (2007)

Regulation of Ov2 by virus encoded microRNAs
por: Nightingale, Katie, et al.
Publicado: (2019)

Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1
por: Jiang, Jiu, et al.
Publicado: (2016)

The genome of Onchocerca volvulus, agent of river blindness
por: Cotton, James A., et al.
Publicado: (2016)

Development of a preliminary in vitro drug screening assay based on a newly established culturing system for pre-adult fifth-stage Onchocerca volvulus worms
por: Voronin, Denis, et al.
Publicado: (2019)

Concordance between Ov16 rapid diagnostic test(RDT) and Ov16 enzyme-linked immunosorbent assay (ELISA) for the diagnosis of onchocerciasis in areas of contrasting endemicity in cameroon
por: Ekanya, Relindis, et al.
Publicado: (2023)

Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines
por: Jiang, Jiu, et al.
Publicado: (2014)

Temperature‐sensitive Ovarian Carcinoma Cell Line (OvBH‐1)
por: Bar, Julia K., et al.
Publicado: (2002)

Adaptation and Validation of the Lithuanian-Language Version of the Olympic Value Scale (OVS)
por: Sukys, Saulius, et al.
Publicado: (2022)

ASimOV: A Framework for Simulation and Optimization of an Embedded AI Accelerator
por: Hwang, Dong Hyun, et al.
Publicado: (2021)

Diagnosis of Ovarian Vein Syndrome (OVS) by Computed Tomography (CT) Imaging: A Retrospective Study of 11 Cases
por: Wang, Ruizhi, et al.
Publicado: (2014)

Murine Oviductosomes (OVS) microRNA profiling during the estrous cycle: Delivery of OVS-borne microRNAs to sperm where miR-34c-5p localizes at the centrosome
por: Fereshteh, Zeinab, et al.
Publicado: (2018)

Dual Protonophore–Chitinase Inhibitors Dramatically Affect O. volvulus Molting
por: Gooyit, Major, et al.
Publicado: (2014)

Andre{breve}i Rubl{llig}i{rlig}ov strasti po Andre{llig}i{rlig}u /
Publicado: (1998)

Molecular cloning of an immunodominant antigen of Onchocerca volvulus
Publicado: (1988)

Interruption of Onchocerca volvulus transmission in Northern Venezuela
por: Convit, Jacinto, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gehkvdace30qnc7lfmkiosnjfl